1. Home
  2. IBAC vs TSVT Comparison

IBAC vs TSVT Comparison

Compare IBAC & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IBAC
  • TSVT
  • Stock Information
  • Founded
  • IBAC 2020
  • TSVT 2021
  • Country
  • IBAC United States
  • TSVT United States
  • Employees
  • IBAC N/A
  • TSVT N/A
  • Industry
  • IBAC
  • TSVT Biotechnology: Pharmaceutical Preparations
  • Sector
  • IBAC
  • TSVT Health Care
  • Exchange
  • IBAC Nasdaq
  • TSVT Nasdaq
  • Market Cap
  • IBAC 159.4M
  • TSVT 128.5M
  • IPO Year
  • IBAC 2024
  • TSVT N/A
  • Fundamental
  • Price
  • IBAC $10.18
  • TSVT $2.45
  • Analyst Decision
  • IBAC
  • TSVT Buy
  • Analyst Count
  • IBAC 0
  • TSVT 6
  • Target Price
  • IBAC N/A
  • TSVT $10.40
  • AVG Volume (30 Days)
  • IBAC 91.1K
  • TSVT 449.7K
  • Earning Date
  • IBAC 01-01-0001
  • TSVT 03-04-2025
  • Dividend Yield
  • IBAC N/A
  • TSVT N/A
  • EPS Growth
  • IBAC N/A
  • TSVT N/A
  • EPS
  • IBAC 0.19
  • TSVT N/A
  • Revenue
  • IBAC N/A
  • TSVT $45,620,000.00
  • Revenue This Year
  • IBAC N/A
  • TSVT N/A
  • Revenue Next Year
  • IBAC N/A
  • TSVT $36.09
  • P/E Ratio
  • IBAC $52.42
  • TSVT N/A
  • Revenue Growth
  • IBAC N/A
  • TSVT N/A
  • 52 Week Low
  • IBAC $9.93
  • TSVT $2.35
  • 52 Week High
  • IBAC $10.26
  • TSVT $6.40
  • Technical
  • Relative Strength Index (RSI)
  • IBAC N/A
  • TSVT 36.05
  • Support Level
  • IBAC N/A
  • TSVT $2.36
  • Resistance Level
  • IBAC N/A
  • TSVT $2.70
  • Average True Range (ATR)
  • IBAC 0.00
  • TSVT 0.18
  • MACD
  • IBAC 0.00
  • TSVT 0.01
  • Stochastic Oscillator
  • IBAC 0.00
  • TSVT 17.11

About IBAC IB Acquisition Corp. Common Stock

IB Acquisition Corp is a blank check company.

About TSVT 2seventy bio Inc.

2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.

Share on Social Networks: